Chris Schelling
2019
In 2019, Chris Schelling earned a total compensation of $1.5M as President and Chief Executive Officer at Opexa Therapeutics, a 167% increase compared to previous year.
Compensation breakdown
| Option Awards | $1,031,211 |
|---|---|
| Salary | $436,000 |
| Total | $1,467,211 |
Schelling received $1M in option awards, accounting for 70% of the total pay in 2019.
Schelling also received $436K in salary.
Rankings
In 2019, Chris Schelling's compensation ranked 7,412th out of 13,971 executives tracked by ExecPay. In other words, Schelling earned more than 46.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,412 out of 13,971 | 47th |
Division Manufacturing | 2,867 out of 5,695 | 50th |
Major group Chemicals And Allied Products | 1,074 out of 2,194 | 51st |
Industry group Drugs | 915 out of 1,880 | 51st |
Industry Pharmaceutical Preparations | 676 out of 1,392 | 51st |
Source: SEC filing on October 14, 2020.
Schelling's colleagues
We found two more compensation records of executives who worked with Chris Schelling at Opexa Therapeutics in 2019.
News
Opexa Therapeutics CEO Chris Schelling's 2022 pay jumps 51% to $834K
April 14, 2023
Opexa Therapeutics Chief Business Officer Jefferson Davis receives $635K in 2021
April 15, 2022
Opexa Therapeutics CEO Chris Schelling's 2020 pay falls 54% to $676K
April 16, 2021
Opexa Therapeutics CEO Chris Schelling's 2019 pay jumps 167% to $1.5M
October 14, 2020
Opexa Therapeutics CEO Chris Schelling's 2018 pay slips 6% to $550K
April 12, 2019